Barriers and facilitators to hepatitis C treatment for people who use drugs

Through qualitative interviews with HCV treatment providers and people who inject drugs (PWID) this research explores the experience of HCV treatment access and delivery from patient, provider and ‘system’ perspectives in order to develop guidance regarding HCV treatment system improvement, including referral and coordination, and the provision of psycho-social interventions targeting patients and providers.

The study concludes with some recommendations on areas where changes to practice or policy could improve HCV treatment uptake and success rates among PWID.

Read here the full publication [restricted access].

Keep up-to-date with drug policy developments by subscribing to the IDPC Monthly Alert.